Hutchison China Meditech Limited Director's Share Dealing (9176P)
23 November 2016 - 6:34PM
UK Regulatory
TIDMHCM
RNS Number : 9176P
Hutchison China Meditech Limited
23 November 2016
Director's Share Dealing
London: Wednesday, November 23, 2016: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification
that Mr Michael Howell, Independent Non-executive Director, sold
10,000 ordinary shares of US$1.00 each in Chi-Med (the "Ordinary
Shares") at an average price of GBP18.83 per share on November 18,
2016 and November 21, 2016 under a personal share trading plan (the
"Plan"). Pursuant to the Plan, a total of 20,000 Ordinary Shares
have now been sold. Previously under the Plan 10,000 Ordinary
Shares were sold between October 24, 2016 and October 28, 2016 and
announced on November 1, 2016. The Plan was put in place by Mr
Howell to facilitate a financial settlement arising from a marital
separation agreement.
Following the above sale of 10,000 Ordinary Shares, the holding
of Mr Howell is 118,600 Ordinary Shares, representing approximately
0.20% of the current issued share capital of Chi-Med.
The notification set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
---- --------------------------------------------------------------------------------------------------------------
a) Name Mr Michael Howell
---- ------------------------------------------------------------- -----------------------------------------------
2 Reason for the notification
---- --------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-executive Director of Chi-Med
---- ------------------------------------------------------------- -----------------------------------------------
b) Initial notification/Amendment Initial notification
---- ------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- --------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
---- ------------------------------------------------------------- -----------------------------------------------
b) LEI N/A
---- ------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- --------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary Shares of US$1.00 each
Identification code DI ISIN: KYG4672N1016
ADS ISIN: US44842L1035
---- ------------------------------------------------------------- -----------------------------------------------
b) Nature of the transaction Sale of 5,000 Ordinary Shares on November 18, 2016 and 5,000 Ordinary Shares on
November 21,
2016 at an average price of GBP18.83
---- --------------------------- -----------------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
GBP18.80 5,000
---------- ----------
GBP18.90 3,000
---------- ----------
GBP18.80 2,000
---------- ----------
---- --------------------------- -----------------------------------------------------------------------------------
d) Aggregated information Aggregated volume: 10,000
- Aggregated volume Price information: GBP18.83
- Price
---- --------------------------- -----------------------------------------------------------------------------------
e) Date of the transaction 2016-11-18 - disposal of 5,000 Ordinary Shares
2016-11-21 - disposal of 5,000 Ordinary Shares
---- --------------------------- -----------------------------------------------------------------------------------
f) Place of the transaction London Stock Exchange (XLON)
---- --------------------------- -----------------------------------------------------------------------------------
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited (SEHK: 0001). For more information,
please visit: www.chi-med.com.
Contacts
Investor Enquiries
Christian Hogg, CEO +852 2121 8200
International Media Enquiries
Anthony Carlisle, +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
Citigate Dewe Rogerson
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Citigate Dewe Rogerson
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFVDLFLVFIR
(END) Dow Jones Newswires
November 23, 2016 02:34 ET (07:34 GMT)
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Apr 2024 to May 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From May 2023 to May 2024